Navigating Healthcare's Gray Areas

This chapter examines the complexities of healthcare policies, focusing on the FDA's conflict of interest and the necessity for improved drug and vaccine safety systems. It highlights the tension between skepticism of popular treatments and the need for rigorous scientific backing, while addressing significant concerns related to vaccine policies and ethical drug approvals. Ultimately, the discussion critiques the commercialization of health and calls for a more evidence-based approach to medical practices.